T1	chemical 42 49	ethanol
T2	disease_or_phenotypic_feature 59 64	tumor
T3	disease_or_phenotypic_feature 107 120	breast cancer
T4	disease_or_phenotypic_feature 217 231	homocystinuria
T5	chemical 243 253	methionine
T6	disease_or_phenotypic_feature 371 377	cancer
T7	chemical 398 405	heparin
T8	corrected_chemical 398 414	heparin mimetics
T9	chemical 419 429	inhibitors
T10	corrected_chemical 419 443	inhibitors of heparanase
T11	corrected_chemical 457 480	TF pathway inhibitor 2.
T12	chemical 460 477	pathway inhibitor
T13	chemical 510 520	inhibitors
T14	disease_or_phenotypic_feature 562 579	bleeding tendency
T15	chemical 602 606	mRNA
T16	disease_or_phenotypic_feature 629 632	PCa
T17	chemical 767 787	ALOX12-12-HETE-GPR31
T18	disease_or_phenotypic_feature 816 819	HCC
T19	disease_or_phenotypic_feature 885 888	HCC
T20	chemical 917 922	fatty
T21	disease_or_phenotypic_feature 1011 1018	amyloid
T22	chemical 1073 1082	histidine
T23	chemical 1073 1091	histidine residues
T24	disease_or_phenotypic_feature 1095 1104	amyloid-Î²
T25	chemical 1184 1191	glucose
T26	chemical 1193 1198	lipid
T27	chemical 1204 1214	amino acid
T28	chemical 1225 1231	enzyme
T29	chemical 1262 1271	molecular
T30	disease_or_phenotypic_feature 1303 1308	tumor
T31	missed_chemical 1374 1385	Galantamine
T32	chemical 1390 1410	Methadone-Maintained
T33	chemical 1428 1435	Cocaine
T35	disease_or_phenotypic_feature 1440 1448	Disorder
T36	chemical 1528 1535	glucose
T37	chemical 1560 1576	glucose-lowering
T38	chemical 1600 1609	metformin
T39	disease_or_phenotypic_feature 1635 1657	cardiovascular disease
T40	corrected_chemical 1698 1739	glucagon-like peptide-1 receptor agonists
T41	chemical 1712 1721	peptide-1
T42	chemical 1722 1739	receptor agonists
T43	missed_chemical 1741 1749	GLP-1RAs
T44	chemical 1755 1769	sodium-glucose
T45	corrected_chemical 1755 1801	sodium-glucose cotransporter type 2 inhibitors
T46	chemical 1791 1801	inhibitors
T47	missed_disease_or_phenotypic_feature 1906 1910	CVD.
T48	chemical 1965 1973	polymers
T49	disease_or_phenotypic_feature 2024 2028	(PCL
T50	chemical 2030 2039	polyester
T51	disease_or_phenotypic_feature 2293 2311	status epilepticus
T52	chemical 2371 2381	monoamines
T53	disease_or_phenotypic_feature 2470 2482	disease-free
T54	chemical 2518 2523	group
T55	chemical 2581 2590	Thiazides
T56	disease_or_phenotypic_feature 2595 2618	nonmelanoma skin cancer
T57	disease_or_phenotypic_feature 2677 2680	CPP
T58	chemical 2677 2680	CPP
T59	disease_or_phenotypic_feature 2778 2794	Undifferentiated
T60	chemical 2859 2865	IGF-I-
T61	chemical 3098 3104	carbon
T62	disease_or_phenotypic_feature 3135 3138	CdS
T63	chemical 3139 3148	nanowires
T64	disease_or_phenotypic_feature 3150 3153	CdS
T65	chemical 3163 3189	luminol-gold nanoparticles
T66	chemical 3268 3281	Poly-Arginine
T68	chemical 3282 3292	Peptide-18
T70	disease_or_phenotypic_feature 3307 3319	Brain Injury
T71	disease_or_phenotypic_feature 3375 3381	Stroke
T72	chemical 3431 3435	lead
T73	chemical 3475 3479	zinc
T74	chemical 3520 3523	DNA
T76	disease_or_phenotypic_feature 3532 3537	blood
T77	corrected_disease_or_phenotypic_feature 3532 3553	blood cell aberration
T78	chemical 3558 3567	oxidative
T80	chemical 3585 3589	lead
T81	disease_or_phenotypic_feature 3633 3638	blood
T82	chemical 3707 3714	calcium
T83	chemical 3723 3734	antagonists
T84	chemical 3736 3747	angiotensin
T85	chemical 3759 3765	enzyme
T86	chemical 3759 3776	enzyme inhibitors
T87	chemical 3782 3792	inhibitors
T88	chemical 3892 3897	lipid
T89	chemical 3898 3910	peroxidation
T90	disease_or_phenotypic_feature 3942 3957	atherosclerosis
T91	disease_or_phenotypic_feature 3961 3985	type 2 diabetes mellitus
R1	FIXME Arg1:T40 Arg2:T47
R2	causes_or_contributes_to Arg1:T80 Arg2:T77
R5	treats Arg1:T31 Arg2:T35
R6	causes_or_contributes_to Arg1:T33 Arg2:T35
R9	treats Arg1:T1 Arg2:T2
R10	treats Arg1:T1 Arg2:T3
R11	FIXME Arg1:T45 Arg2:T47
R12	treats Arg1:T38 Arg2:T39
R13	FIXME Arg1:T43 Arg2:T47
T92	corrected_chemical 1390 1399	Methadone
R16	treats Arg1:T92 Arg2:T35	
T93	missed_disease_or_phenotypic_feature 1659 1662	CVD
R17	treats Arg1:T38 Arg2:T93	
T67	missed_chemical 1803 1810	SGLT2is
R8	treats Arg1:T67 Arg2:T47	
R15	treats Arg1:T43 Arg2:T47	
R19	treats Arg1:T40 Arg2:T47	
R14	treats Arg1:T45 Arg2:T47	
T69	corrected_chemical 3268 3292	Poly-Arginine Peptide-18
R18	treats Arg1:T69 Arg2:T70	
R20	treats Arg1:T69 Arg2:T71	
T75	corrected_disease_or_phenotypic_feature 3622 3647	increasing blood pressure
T79	corrected_chemical 3707 3734	calcium channel antagonists
T94	corrected_chemical 3736 3776	angiotensin converting enzyme inhibitors
T95	corrected_chemical 3778 3792	ACE inhibitors
T96	corrected_chemical 3798 3821	selective beta-blockers
R3	treats Arg1:T96 Arg2:T75	
R4	treats Arg1:T79 Arg2:T75	
R21	treats Arg1:T94 Arg2:T75	
R22	treats Arg1:T95 Arg2:T75	
T97	corrected_chemical 510 534	inhibitors of heparanase
R23	treats Arg1:T97 Arg2:T14	
T98	missed_chemical 3294 3297	R18
R7	treats Arg1:T98 Arg2:T70	
R24	treats Arg1:T98 Arg2:T71	
T34	corrected_chemical 1560 1583	glucose-lowering agents
T99	missed_disease_or_phenotypic_feature 1855 1876	cardiovascular events
R25	treats Arg1:T67 Arg2:T99	
R26	treats Arg1:T45 Arg2:T99	
R27	treats Arg1:T43 Arg2:T99	
R28	treats Arg1:T40 Arg2:T99	
T100	missed_disease_or_phenotypic_feature 1491 1501	Opioid Use
R29	treats Arg1:T31 Arg2:T100	
